On the day of the last hearing in...Novartis' legal challenge against India's Patents Act...Doctors Without Borders/Medecins Sans Frontieres (MSF) strongly condemns Novartis for pushing forward with the case and is asking the company's shareholders to urge CEO Vasella to withdraw the legal challenge in India, which could jeopardize worldwide access to essential medicines...Increased availability and affordability of antiretroviral drugs is what allowed MSF and others to start treating HIV/AIDS patients around the world since 2000...Over 80 percent of the medicines MSF uses to treat AIDS come from India.